Company Filing History:
2 out of 2 
1 out of 1 
1 out of 48 
Years Active: 2018-2022
Title: Armelle Cuvillier: Innovator in Cancer Therapy and HIV Research
Introduction
Armelle Cuvillier is a notable inventor based in Saint-Jouvent, France. She has made significant contributions to the fields of cancer therapy and HIV research. With a total of 3 patents, her work focuses on developing innovative solutions to combat serious health issues.
Latest Patents
Cuvillier's latest patents include groundbreaking inventions. One of her notable patents is for antibodies against carcinoembryonic antigen (CEA) for cancer therapy and diagnosis. This invention relates to antibodies that exhibit direct cell growth inhibition activity on tumor cells expressing CEA, providing a promising avenue for cancer treatment and diagnosis. Another significant patent involves a non-HIV vaccine antigen derived from the vaginal microbiota. This antigen is capable of inducing a mucosal neutralizing protective antibody response against HIV infection, which could lead to new vaccine developments against pathogens.
Career Highlights
Throughout her career, Armelle Cuvillier has worked with various companies, including B Cell Design and B Cell Design Sas. Her innovative work has positioned her as a key figure in her field, contributing to advancements in medical research and therapeutic solutions.
Collaborations
Cuvillier has collaborated with notable individuals in her field, including Gaël Champier and Raphaëlle Claude El Habib. These collaborations have further enhanced her research and development efforts.
Conclusion
Armelle Cuvillier's contributions to cancer therapy and HIV research highlight her innovative spirit and dedication to improving health outcomes. Her patents represent significant advancements in medical science, showcasing her role as a leading inventor in her field.